Michael Blaha, MD, highlights the potential of GLP-1 agonists in lowering LDL cholesterol, triglycerides, and body weight in patients with diabetes, presenting them as an additional option for reducing cardiovascular risk in this patient population.
Emory study finds 'invisible threat' to kids from secondhand vape exposure ajc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ajc.com Daily Mail and Mail on Sunday newspapers.
To ban or not to ban e-cigarettes? - VnExpress International vnexpress.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vnexpress.net Daily Mail and Mail on Sunday newspapers.